Zhenzhou Shen

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Fiberoptic ductoscopy for patients with nipple discharge

Kunwei Shen, Jiong Wu, Jingsong Lu et al. · Cancer · 2000 · 101 citations · Full text

Fiberoptic ductoscopy for breast cancer patients with nipple discharge

Kunwei Shen, Jiong Wu, Jun-Xia Lu et al. · Surgical Endoscopy · 2001 · 70 citations

Nipple Discharge, Breast Cancer, Surgery +2

Analysis of the contribution of multiple factors to the recent decrease in discharge and sediment yield in the Yellow River Basin, China

Wenyi Yao, Peiqing Xiao, Zhenzhou Shen et al. · Journal of Geographical Sciences · 2016 · 48 citations

River Basin Management, Yellow River Basin, Engineering +11